ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

16.33
Delayed Data
As of Jun 22
 +0.38 / +2.38%
Today’s Change
14.51
Today|||52-Week Range
41.20
-45.77%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baity Glenn F
General Counsel & Executive Vice President
Sale1/02/201874,321$30.14$2.2M-46.34%
Baity Glenn F
General Counsel & Executive Vice President
Sale1/29/201836,558$32.39$1.2M-48.55%
Baity Glenn F
General Counsel & Executive Vice President
Sale7/20/201738,097$30.00$1.1M-45.73%
Baity Glenn F
General Counsel & Executive Vice President
Sale8/30/201726,507$34.87$924.3K-52.97%
Brege Laura A
Director
Sale1/02/201825,000$30.06$751.5K-46.34%
Baity Glenn F
General Counsel & Executive Vice President
Sale8/09/201714,322$34.88$499.6K-50.83%
Baity Glenn F
General Counsel & Executive Vice President
Buy1/02/201874,321$2.18$162.0K-46.34%
Brege Laura A
Director
Buy1/02/201815,000$8.06$120.9K-46.34%
Baity Glenn F
General Counsel & Executive Vice President
Buy1/10/201850,179$2.18$109.4K-42.96%
Brege Laura A
Director
Buy1/02/201810,000$8.49$84.9K-46.34%
Page of 3